The Cholesterol Bet
Taking lessons from a failed drug, firms are ready to test a heart health hypothesis
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
February 20, 2012 Cover
Volume 90, Issue 8
Taking lessons from a failed drug, firms are ready to test a heart health hypothesis
Cover image:
Credit:
Taking lessons from a failed drug, firms are ready to test a heart health hypothesis
In light of controversial H5N1 bird flu experiments, experts hashed out myriad issues at a public forum in New York City
Public portals to computed data and search tools are set to accelerate the pace of materials discovery
Coherent waves may enhance energy transfer
After a brisk first quarter, big spending on chemical acquisitions slowed in 2011
The science historian discovers flaws in original design and implementation of much-debated Toxic Substances Control Act
MRI method generates diagnostic images that reveal normally hidden details of electrodes and electrolytes